Keyphrases
Denmark
100%
Greenland
100%
Highly Active Antiretroviral Therapy (HAART)
100%
HIV Patients
100%
Infected Population
100%
Drug Failure
41%
Temporal Trends
25%
Antiretroviral Therapy Initiation
25%
Drug-resistant Virus
25%
HIV Cohort
16%
Undetectable Viral Load
16%
HIV Viral Load
16%
Viral Suppression
16%
Antiviral Drugs
16%
Nucleoside Reverse Transcriptase Inhibitors
16%
Viral Load Suppression
16%
Unnatural nucleotides
16%
Incident Cases
8%
Poisson Regression
8%
Multivariate Modeling
8%
Therapeutic Potential
8%
Delayed Diagnosis
8%
Calendar Time
8%
Treatment History
8%
Prospective Cohort Study
8%
Incidence Rate
8%
Demographic Characteristics
8%
Risk of Death
8%
New Drugs
8%
Days of Treatment
8%
Clinical Efficacy
8%
Middle-aged
8%
Logistic Regression
8%
Long-term Survival
8%
Nave
8%
CD4 Count
8%
Infected Individual
8%
Drug Class
8%
Patient Characteristics
8%
Therapeutic Strategies
8%
Clinical Improvement
8%
Epidemiological Study
8%
Young Age
8%
Clinical Events
8%
Patients at Risk
8%
Potential Drugs
8%
Individuals at Risk
8%
Virological Failure
8%
Sustained Viral Suppression
8%
Linear Regression
8%
Number of Deaths
8%
New Infections
8%
Population Level
8%
Student's T-test
8%
Biochemical Tests
8%
Immune Status
8%
Multidrug
8%
Drug Resistance
8%
Poor Adherence
8%
Therapy Treatment
8%
One-way Analysis of Variance
8%
Drug-resistant HIV
8%
Heterosexual Contact
8%
Early Years
8%
Chi-square Test
8%
Dual Drug
8%
Immunological Outcomes
8%
Advanced HIV Disease
8%
Transmission Risk
8%
Confounding Control
8%
Drug Risk
8%
Cox Proportional Hazards Regression
8%
Suppressed Viral Load
8%
Survival Improvement
8%
Positive Development
8%
Therapeutic Effectiveness
8%
Drug Toxicity
8%
Tion
8%
Treatment Improvement
8%
Recent HIV Infection
8%
Ment
8%
Spearman Rank
8%
Analysis Modeling
8%
Regression Logistic
8%
Nuuk
8%
Design Requirements
8%
Multi-class
8%
HIV Cases
8%
Non-suppression
8%
Infectious Patients
8%
Progres
8%
Ting
8%
Resis
8%
Mathematics
Proportional Hazards Model
100%
Test Result
100%
Confounding
100%
Poisson Regression
100%
Incidence Rate
100%
Individual Patient
100%
Population Level
100%
Logistic Regression
100%
Linear Regression
100%
Student's t-Test
100%
Analysis of Variance
100%
Chi-Square Testing
100%
Proportional Hazard Regression
100%
Medicine and Dentistry
Observational Study
100%
Human Immunodeficiency Virus
100%
Highly Active Antiretroviral Therapy
100%
Prevalence
23%
Disease
11%
Cohort Analysis
11%
Nucleoside Analogue
11%
Reverse-Transcriptase Inhibitor
11%
Population
5%
Infection
5%
Prospective Cohort Study
5%
Logistic Regression Analysis
5%
Long Term Survival
5%
Proportional Hazards Model
5%
Patient Characteristics
5%
Middle Age
5%
Linear Regression Analysis
5%
Human Immunodeficiency Virus Infection
5%
Demography
5%
Student T Test
5%
Drug Resistance
5%
Chi Square Test
5%
Doctor of Philosophy
5%
Analysis of Variance
5%
Virus RNA
5%
Drug Toxicity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
HIV
100%
Prevalence
23%
Cohort Study
11%
Disease
11%
Nucleoside Analog
11%
RNA Directed DNA Polymerase Inhibitor
11%
Prospective Cohort Study
5%
Infection
5%
Human Immunodeficiency Virus Infection
5%
Drug Resistance
5%
Long Term Survival
5%
Virus RNA
5%
Drug Toxicity
5%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Viral Load
29%
Prevalence
23%
Reverse Transcriptase
11%
Population
5%
Blood Plasma
5%
Long Term Survival
5%
Human Immunodeficiency Virus Infection
5%
CD4 Lymphocyte Count
5%
Drug Resistance
5%
Demography
5%
Drug Toxicity
5%